3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
1
Hodgkin Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
8
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
6
Flow Cytometry
6
Whole-Body Irradiation
5
Therapeutics
5
Cyclosporine
5
Radiotherapy
4
Polymerase Chain Reaction
4
Busulfan
4
Antilymphocyte Serum
4
Vorinostat
3
Tacrolimus
3
Nivolumab
3
Methylprednisolone
3
Methotrexate
3
Immunoenzyme Techniques
3
Carboplatin
3
Amplified Fragment Length Polymorphism Analysis
3
Alemtuzumab
3
thymoglobulin
2
pembrolizumab
2
liposomal amphotericin B
2
durvalumab
2
Thiotepa
2
Sunitinib
2
Specimen Handling
2
Psychiatric Rehabilitation
2
Prednisone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
RXDX-106
×
Genitourinary
×
Clear all
NCT03454243
2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1
Terminated
1 enrolled